Vascudyne

About:

Vascudyne is developing, manufacturing, and commercializing regenerative acellular in-vitro grown “allograft” tissue.

Website: https://www.vascudyne.com/indexs.php

Top Investors: Regenerative Medicine Minnesota

Description:

Vascudyne is developing, manufacturing, and commercializing regenerative acellular in-vitro grown “allograft” tissue. Vascudyne is the world's leading center of excellence for developing and manufacturing engineered tissue. We provide our clients with world-class engineered tissue, unique engineered tissue-based device designs, manufacturing capabilities, technical expertise, and product development support.

Total Funding Amount:

$18.6M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Plano, Texas, United States

Founded Date:

2014-01-01

Founders:

Jeff Franco, Kem Schankereli

Number of Employees:

1-10

Last Funding Date:

2022-05-10

IPO Status:

Private

Industries:

© 2025 bioDAO.ai